Cargando…

P-097: KNOWLEDGE AND EXPERIENCES OF PARENTS WITH CHILDREN AFFECTED BY SICKLE CELL DISEASE FOLLOWED AT CHUK: A QUALITATIVE STUDY

Detalles Bibliográficos
Autores principales:	P., HAVUGARUREMA, N., NYIRIMANZI, A., KANYAMUHUNGA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429837/ http://dx.doi.org/10.1097/01.HS9.0000873276.80032.b4

Ejemplares similares

P097: Antimicrobial usage in the treatment of patients with bloodstream infection
por: Paula, AO, et al.
Publicado: (2013)

P097 Sleep, Fatigue and Depression in Young Autistic Adults
por: Richdale, A, et al.
Publicado: (2022)

P097 The Fate of Obstructive Sleep Apnea in Long-term
por: Jang, H, et al.
Publicado: (2023)

Chuk y Guek
por: Gaidar, Arkadi, 1904-1941
Publicado: (1954)

P097 Incidence of abnormal dreams and nightmares with lemborexant in adults with insomnia: results from two Phase 3 studies
por: Roth, T, et al.
Publicado: (2021)

O097: Abstract withdrawn
Publicado: (2013)

P-094: EXPLORING SCHOOL LIVED EXPERIENCES OF SECONDARY STUDENTS WITH SICKLE CELL DISEASE THROUGH THEIR PARENTS’ LENS
por: C., HARDEN
Publicado: (2022)

AB097. KH-204 reduces oxidative stress-induced testicular apoptosis via ERK and Akt pathways
por: Bae, Woong Jin, et al.
Publicado: (2016)

P097 Epidemiology of dermatophytes related infections in Kuwait: a retrospective study
por: Al-Aryan, Anoud, et al.
Publicado: (2022)

P126: HEALTH LITERACY AND DISEASE KNOWLEDGE IN YOUNG PERSONS WITH SICKLE CELL DISEASE
por: Ikediashi, B, et al.
Publicado: (2022)

P-093: PREVALENCE, KNOWLEDGE AND CLINICAL FEATURES OF PRIAPISM IN SICKLE CELL DISEASE IN SENEGAL
por: M., SECK, et al.
Publicado: (2022)

P129: NARRATING SICKLE CELL DISEASE: THE EXPERIENCES OF PATIENTS AND CARGIVERS
por: De Franceschi, L, et al.
Publicado: (2022)

P097 How much we know about Pediatric Advanced Life Support 2021 guidelines – national survey
por: Hasani, Antigona, et al.
Publicado: (2022)

P111: COVID-19 IN PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE: A SINGLE CENTER EXPERIENCE
por: Dimopoulou, M, et al.
Publicado: (2022)

P123: A SYSTEMATIC REVIEW OF THE BARRIERS TO UPTAKE AND ADHERENCE TO HYDROXYCARBAMIDE FROM THE PERSPECTIVE OF CHILDREN AND ADULTS WITH SICKLE CELL DISEASE, PARENTS AND CLINICIANS.
por: Clark, C
Publicado: (2022)

P-036: PIEZO1 ACTIVATION AUGMENTS SICKLING PROPENSITY AND THE ADHESIVE PROPERTIES OF SICKLE RED BLOOD CELLS
por: N., CONRAN, et al.
Publicado: (2022)

P-053: SICKLE CELL MANAGEMENT AND INTERNATIONAL COOPERATION
por: I., DEME LY, et al.
Publicado: (2022)

P116: THE IMPACT OF COVID19 PANDEMIC ON SICKLE CELL MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC CENTER
por: Maria Vousvouki, M, et al.
Publicado: (2022)

P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA
por: S., GRAVEN, et al.
Publicado: (2022)

P108: ASSESSMENT OF HEALTHCARE WORKERS’ KNOWLEDGE AND RESOURCE AVAILABILITY FOR CARE OF SICKLE CELL DISEASE AT HEALTH FACILITIES IN DAR ES SALAAM, TANZANIA
por: Jonathan, A, et al.
Publicado: (2022)

P-021: THE LIVING WELL WITH SICKLE CELL MOBILE APPLICATION
por: A., MATTHEWS, et al.
Publicado: (2022)

MiRNA-223-3p Affects Mantle Cell Lymphoma Development by Regulating the CHUK/NF-ƘB2 Signaling Pathway
por: Yuan, Jingjing, et al.
Publicado: (2021)

P-005: COMPARISON OF SICKLE SCAN AND HEMOTYPE SC AS POINT-OF-CARE NEWBORN SCREENING DIAGNOSTICS FOR SICKLE CELL DISEASE IN LUANDA, ANGOLA
por: B., SANTOS, et al.
Publicado: (2022)

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis
por: Li, Xin, et al.
Publicado: (2021)

P-033: CLINICAL AND HEMATOLOGICAL FOLLOW UP OF SICKLE CELL DISEASE PATIENTS IN A REMOTE CITY IN A COUNTRY WITH LIMITED RESOURCES
por: B., MBIYA-MUKINAYI, et al.
Publicado: (2022)

Knowledge of confidentiality, consent and information disclosure is not affected by position or experience in adult critical care
por: Lowings, M, et al.
Publicado: (2013)

P101: GUT MICROBIOTA IMPACT ON ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
por: Brito, M, et al.
Publicado: (2022)

P-088: MELIOIDOSIS AND SICKLE CELL DISEASE: DESCRIPTION OF A RARE ASSOCIATION
por: S., YA PONGOMBO, et al.
Publicado: (2022)

P-038: PREGNANCY OUTCOMES AMONG PATIENTS WITH SICKLE CELL DISEASE IN BRAZZAVILLE.
por: F., ATIPO-TSIBA GALIBA, et al.
Publicado: (2022)

P-056: SICKLE CELL DISEASE: DIAGNOTIC CHALLENGES AND FUTURE PERSPECTIVE IN NICARAGUA
por: A., PERNUDY UBAU, et al.
Publicado: (2022)

P-008: PREVALENCE AND PREDICTORS OF PULMONARY HYPERTENSION IN PAEDIATRIC SICKLE CELL DISEASE
por: T., LAKHERA, et al.
Publicado: (2022)

P-032: INTEGRATIVE DIAGNOSIS OF SICKLE CELL DISEASE PATIENTS FOR PERSONALIZED MEDICINE
por: A., IDRIZOVIC, et al.
Publicado: (2022)

P127: HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON- A REAL-WORLD EXPERIENCE
por: Adlette Inati, A, et al.
Publicado: (2022)

P02.153. Effectiveness of biofield therapy for patients with sickle cell disease in Africa
por: Mikobi, M, et al.
Publicado: (2012)

P110: CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS
por: Malhan, H, et al.
Publicado: (2022)

P-046: FACTORS ASSOCIATED WITH LEG ULCERS IN CAMEROONIAN SICKLE CELL DISEASE PATIENTS
por: C., EPOSSE, et al.
Publicado: (2022)

P-077: POTENTIAL BIOMARKERS IN THE PREVENTIVE DIAGNOSIS OF ACUTE COMPLICATIONS IN SICKLE CELL DISEASE
por: I., MOUMNI, et al.
Publicado: (2022)

P-050: UNDERSTANDING BARRIERS TO AND ENABLERS IN EMPLOYMENT FOR PEOPLE WITH SICKLE CELL DISORDERS IN ENGLAND
por: M., BERGHS, et al.
Publicado: (2022)

P-099: ANTI-SICKLING STUDY OF THE AQUEOUS EXTRACTS OF TINOSPORA CARDIFOLIA AND TERMINALIA BELLIRICA
por: S., PATRA
Publicado: (2022)

P-092: RED BLOOD CELL GLUCOSE CONSUMPTION AND METABOLISM IN SICKLE CELL DISEASE
por: A., RAJESH, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aahpffe6jv0u69a4avcrnaonk0